This study has explored the temporal relationship between
apoprotein(a), blood pressure and
albuminuria over a mean interval of 11 years in a cohort of 107 diabetic patients of whom 26 (14 Type 2 (non-
insulin-dependent), 12 Type 1 (
insulin-dependent) had progressively increasing
albuminuria ('progressors'). In Type 2 diabetic patients, no significant differences were noted for
HbA1, blood pressure,
creatinine clearance or serum
lipids between progressors and non-progressors. In Type 1 diabetic patients, final systolic and diastolic blood pressures were higher in progressors compared with non-progressors and progressors showed impairment of renal function in association with a rise in blood pressure at the macroalbuminuric stage. Initial
apoprotein(a) levels were similar in progressors and non-progressors of either diabetes type.
Apoprotein(a) levels increased exponentially with time in 12 of 14 Type 2 progressors but only in 5 of 12 Type 1 progressors (p < 0.01). In Type 2 diabetic patients, the annual increase in
apoprotein(a) levels was 9.1 +/- 2.4%, which was significantly greater than in non-progressors, 2.0 +/- 1.2% (p < 0.01) and also exceeded the rates of increase of
apoprotein(a) in progressors with
Type 1 diabetes, 4.0 +/- 1.4%, (p < 0.05).
Apoprotein(a) levels correlated significantly with
albuminuria in 8 of 14 Type 2 progressors but only in 3 of 12 Type 1 progressors (p < 0.05). The rate of increase of
apoprotein(a) levels was not related to mean
HbA1,
creatinine or
creatinine clearance levels, or to
albuminuria.(ABSTRACT TRUNCATED AT 250 WORDS)